Free Trial
OTCMKTS:DHAI

DIH Holding US Q3 2025 Earnings Results & Report

DIH Holding US logo

DIH Holding US reported Q3 2025 earnings on February 14, 2025. The company reported EPS of -$2.75, while revenue was $15.09 million.

Earnings Announcement Details

Quarter
Q3 2025
Time
After Market Closes
Conference Call
4:00 PM ET

DIH Holding US EPS Results

Actual EPS
-$2.75
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

DIH Holding US Revenue Results

Actual Revenue
$15.09 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

DIH Holding US Q3 2025 Earnings FAQ

DIH Holding US (OTCMKTS:DHAI) reported earnings of -$2.75 per share for Q3 2025. The report was announced on Friday, February 14, 2025.

DIH Holding US reported revenue of $15.09 million for Q3 2025.

DIH Holding US Earnings Headlines

Dih Us
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel
See More DIH Holding US Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like DIH Holding US? Sign up for Earnings360's daily newsletter to receive timely earnings updates on DIH Holding US and other key companies, straight to your email.

About DIH Holding US

DIH Holding US (OTCMKTS:DHAI) develops and provides robotic, digital and immersive rehabilitation technologies for hospitals, outpatient clinics, research institutions and other healthcare providers. Its solutions are designed to support the assessment and treatment of patients recovering from neurological, orthopedic and movement-related conditions, as well as broader human-performance and gait-analysis applications.

The company’s product portfolio includes robotic-assisted therapy systems, body-weight-support and gait-training technologies, virtual-reality rehabilitation tools, and motion-analysis platforms. Its offerings include products associated with the Hocoma and Motek businesses, such as the Lokomat, Armeo, Andago, C-Mill, CAREN and GRAIL systems. These platforms combine robotics, sensors, software and data analysis to help clinicians deliver consistent therapy and measure patient progress.

DIH serves healthcare and research organizations internationally through a global commercial and service network. The company was formed around the combination of Hocoma, a Swiss rehabilitation-technology company, and Motek, a Netherlands-based provider of biomechanics and movement-analysis systems. Publicly available information does not provide sufficient verified detail about the company’s current leadership structure to include it reliably.

View DIH Holding US Profile